Cargando…
Antibody CD133 Biofunctionalization of Ammonium Acryloyldimethyltaurate and Vinylpyrrolidone Co-Polymer-Based Coating of the Vascular Implants
Current vascular stents, such as drug eluting stents (DES), have some serious drawbacks, like in stent restenosis and thrombosis. Therefore, other solutions are sought to overcome these post-implantations complications. These include the strategy of biofunctionalization of the stent surface with ant...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763102/ https://www.ncbi.nlm.nih.gov/pubmed/33321837 http://dx.doi.org/10.3390/ma13245634 |
_version_ | 1783627937749139456 |
---|---|
author | Sareło, Przemysław Duda, Maciej Gąsior-Głogowska, Marlena Wysokińska, Edyta Kałas, Wojciech Podbielska, Halina Wawrzyńska, Magdalena Kopaczyńska, Marta |
author_facet | Sareło, Przemysław Duda, Maciej Gąsior-Głogowska, Marlena Wysokińska, Edyta Kałas, Wojciech Podbielska, Halina Wawrzyńska, Magdalena Kopaczyńska, Marta |
author_sort | Sareło, Przemysław |
collection | PubMed |
description | Current vascular stents, such as drug eluting stents (DES), have some serious drawbacks, like in stent restenosis and thrombosis. Therefore, other solutions are sought to overcome these post-implantations complications. These include the strategy of biofunctionalization of the stent surface with antibodies that facilitate adhesion of endothelial cells (ECs) or endothelial progenitor cells (EPCs). Rapid re-endothelialization of the surface minimizes the risk of possible complications. In this study, we proposed ammonium acryloyldimethyltaurate/vinylpyrrolidone co-polymer-based surface (AVC), which was mercaptosilanized in order to expose free thiol groups. The presence of free thiol groups allowed for the covalent attachment of CD133 antibodies by disulfide bridges formation between mercaptosilanized surface and cysteine of the protein molecule thiol groups. Various examinations were performed in order to validate the procedure, including attenuated total reflection–Fourier transform infrared spectroscopy (ATR-FTIR) and Fourier transform Raman spectroscopy (FT-Raman), atomic force microscopy (AFM) and scanning electron microscopy (SEM). By means of ATR-FTIR spectroscopy presence of the CD133 antibody within coating was confirmed. In vitro studies proved good biocompatibility for blood cells without induction of hemolytic response. Thus, proposed biofunctionalized CD133 antibody AVC surface has shown sufficient stability for adapting as cardiovascular implant coating and biocompatibility. According to conducted in vitro studies, the modified surface can be further tested for applications in various biological systems. |
format | Online Article Text |
id | pubmed-7763102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77631022020-12-27 Antibody CD133 Biofunctionalization of Ammonium Acryloyldimethyltaurate and Vinylpyrrolidone Co-Polymer-Based Coating of the Vascular Implants Sareło, Przemysław Duda, Maciej Gąsior-Głogowska, Marlena Wysokińska, Edyta Kałas, Wojciech Podbielska, Halina Wawrzyńska, Magdalena Kopaczyńska, Marta Materials (Basel) Article Current vascular stents, such as drug eluting stents (DES), have some serious drawbacks, like in stent restenosis and thrombosis. Therefore, other solutions are sought to overcome these post-implantations complications. These include the strategy of biofunctionalization of the stent surface with antibodies that facilitate adhesion of endothelial cells (ECs) or endothelial progenitor cells (EPCs). Rapid re-endothelialization of the surface minimizes the risk of possible complications. In this study, we proposed ammonium acryloyldimethyltaurate/vinylpyrrolidone co-polymer-based surface (AVC), which was mercaptosilanized in order to expose free thiol groups. The presence of free thiol groups allowed for the covalent attachment of CD133 antibodies by disulfide bridges formation between mercaptosilanized surface and cysteine of the protein molecule thiol groups. Various examinations were performed in order to validate the procedure, including attenuated total reflection–Fourier transform infrared spectroscopy (ATR-FTIR) and Fourier transform Raman spectroscopy (FT-Raman), atomic force microscopy (AFM) and scanning electron microscopy (SEM). By means of ATR-FTIR spectroscopy presence of the CD133 antibody within coating was confirmed. In vitro studies proved good biocompatibility for blood cells without induction of hemolytic response. Thus, proposed biofunctionalized CD133 antibody AVC surface has shown sufficient stability for adapting as cardiovascular implant coating and biocompatibility. According to conducted in vitro studies, the modified surface can be further tested for applications in various biological systems. MDPI 2020-12-10 /pmc/articles/PMC7763102/ /pubmed/33321837 http://dx.doi.org/10.3390/ma13245634 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sareło, Przemysław Duda, Maciej Gąsior-Głogowska, Marlena Wysokińska, Edyta Kałas, Wojciech Podbielska, Halina Wawrzyńska, Magdalena Kopaczyńska, Marta Antibody CD133 Biofunctionalization of Ammonium Acryloyldimethyltaurate and Vinylpyrrolidone Co-Polymer-Based Coating of the Vascular Implants |
title | Antibody CD133 Biofunctionalization of Ammonium Acryloyldimethyltaurate and Vinylpyrrolidone Co-Polymer-Based Coating of the Vascular Implants |
title_full | Antibody CD133 Biofunctionalization of Ammonium Acryloyldimethyltaurate and Vinylpyrrolidone Co-Polymer-Based Coating of the Vascular Implants |
title_fullStr | Antibody CD133 Biofunctionalization of Ammonium Acryloyldimethyltaurate and Vinylpyrrolidone Co-Polymer-Based Coating of the Vascular Implants |
title_full_unstemmed | Antibody CD133 Biofunctionalization of Ammonium Acryloyldimethyltaurate and Vinylpyrrolidone Co-Polymer-Based Coating of the Vascular Implants |
title_short | Antibody CD133 Biofunctionalization of Ammonium Acryloyldimethyltaurate and Vinylpyrrolidone Co-Polymer-Based Coating of the Vascular Implants |
title_sort | antibody cd133 biofunctionalization of ammonium acryloyldimethyltaurate and vinylpyrrolidone co-polymer-based coating of the vascular implants |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763102/ https://www.ncbi.nlm.nih.gov/pubmed/33321837 http://dx.doi.org/10.3390/ma13245634 |
work_keys_str_mv | AT sarełoprzemysław antibodycd133biofunctionalizationofammoniumacryloyldimethyltaurateandvinylpyrrolidonecopolymerbasedcoatingofthevascularimplants AT dudamaciej antibodycd133biofunctionalizationofammoniumacryloyldimethyltaurateandvinylpyrrolidonecopolymerbasedcoatingofthevascularimplants AT gasiorgłogowskamarlena antibodycd133biofunctionalizationofammoniumacryloyldimethyltaurateandvinylpyrrolidonecopolymerbasedcoatingofthevascularimplants AT wysokinskaedyta antibodycd133biofunctionalizationofammoniumacryloyldimethyltaurateandvinylpyrrolidonecopolymerbasedcoatingofthevascularimplants AT kałaswojciech antibodycd133biofunctionalizationofammoniumacryloyldimethyltaurateandvinylpyrrolidonecopolymerbasedcoatingofthevascularimplants AT podbielskahalina antibodycd133biofunctionalizationofammoniumacryloyldimethyltaurateandvinylpyrrolidonecopolymerbasedcoatingofthevascularimplants AT wawrzynskamagdalena antibodycd133biofunctionalizationofammoniumacryloyldimethyltaurateandvinylpyrrolidonecopolymerbasedcoatingofthevascularimplants AT kopaczynskamarta antibodycd133biofunctionalizationofammoniumacryloyldimethyltaurateandvinylpyrrolidonecopolymerbasedcoatingofthevascularimplants |